The Netherlands Cancer Institute: all 230 studies
Page 3 of 3. Open to participants first (66), then studies with results posted, then the rest; newest registration first within each.
- Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm.CompletedNCT01933568Phase 1
- Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast CancerActive, not recruitingNCT01898117Phase 2
- Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal MetastasesStatus unknownNCT01818713Phase 2
- Hippocampus Avoidance PCI vs PCICompletedNCT01780675Phase 3
- Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal MetastasesCompletedNCT01713699Not applicable
- High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast CancerActive, not recruitingNCT01646034Phase 3
- PET Evaluation of Recurrent Differentiated Thyroid CancerStatus unknownNCT01641679
- The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer GeneticsCompletedNCT01562431Not applicable
- Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLCCompletedNCT01562210Phase 1
- Irradiation of Large Lung Tumors or Two or More Lung Metastases SimultaneouslyCompletedNCT01543672Phase 1/2
- Adaptive Radiation Treatment for Head and Neck CancerCompletedNCT01504815Phase 3
- Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerStatus unknownNCT01359397Phase 2
- Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid TumorsCompletedNCT01286896Phase 1
- Standard Chemotherapy With of Without Axitinib in Malignant MesotheliomaCompletedNCT01211275Phase 1/2
- Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With RitonavirCompletedNCT01173913Phase 1
- Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian CancerCompletedNCT01164995Phase 2
- Neo Adjuvant Chemotherapy in Triple Negative Breast CancerActive, not recruitingNCT01057069Phase 2/3
- Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLCStatus unknownNCT01024829Not applicable
- Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast CancerCompletedNCT01024582Not applicable
- Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With FluoropyrimidinesCompletedNCT00838370Phase 1
- Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer PatientsCompletedNCT00783822Not applicable
- Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN StudyCompletedNCT00768859Phase 2
- Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast CancerSuspendedNCT00738777Phase 2
- Radiotherapy for Prostate Cancer: Conventional Dose Versus High DoseCompletedNCT00692107Phase 3
- Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast CancerTerminatedNCT00684216Phase 2/3
- Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized TrialStatus unknownNCT00582244Phase 3
- Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated CardiotoxicityCompletedNCT00459771Phase 3
- Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRDTerminatedNCT00448266Phase 2/3
- Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian CancerCompletedNCT00426257Phase 3
- Radiation Dose Intensity Study in Breast Cancer in Young WomenActive, not recruitingNCT00212121Phase 3